A total of 21 individuals representing 15 companies across the United States participated in the study (response rate, 45%). The main reasons for nonparticipation were scheduling conflicts and an ...

This study represents the first examination of how pharmaceutical industry representatives involved in marketing view the use of health outcome and pharmacoeconomic information by health care ...